EZH2 and glioblastoma: Also, the knockdown of EZH2 resulted in reduction of MDR, MRP, and BCRP mRNA and protein levels leading to a decrease in efflux pump activity as well as augmented sensitivity to chemotherapy in GBM cells [9].